FDA Drug Application (091452) for MARLISSA by GLENMARK GENERICS

Back to FDA Applications sponsored by GLENMARK GENERICS

Application Number091452
Product Number001
FormTABLET;ORAL-28
Dosage0.03MG;0.15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMARLISSA
Active IngredientETHINYL ESTRADIOL; LEVONORGESTREL

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient LEVONORGESTREL58


Back to FDA Applications sponsored by GLENMARK GENERICS